pubmed-article:17302588 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C0023911 | lld:lifeskim |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C0037995 | lld:lifeskim |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C0032113 | lld:lifeskim |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C0445204 | lld:lifeskim |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C1552428 | lld:lifeskim |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C1555985 | lld:lifeskim |
pubmed-article:17302588 | lifeskim:mentions | umls-concept:C1546466 | lld:lifeskim |
pubmed-article:17302588 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:17302588 | pubmed:dateCreated | 2007-2-16 | lld:pubmed |
pubmed-article:17302588 | pubmed:abstractText | ABO-incompatible living-donor liver transplantation (LDLT) requires a reduction of the anti-ABO antibody titer to <16 before transplantation, which is usually achieved by pre-operative plasma exchange (PE) or double-filtration plasmapheresis. ABO-incompatible transplantations have been performed after a splenectomy with heavy drug immunosupression plus B-cell-specific drugs. Here, we evaluated a pre-transplantation infusion protocol with an anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible LDLT. | lld:pubmed |
pubmed-article:17302588 | pubmed:language | eng | lld:pubmed |
pubmed-article:17302588 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17302588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17302588 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17302588 | pubmed:issn | 0902-0063 | lld:pubmed |
pubmed-article:17302588 | pubmed:author | pubmed-author:SakuraiHiroyu... | lld:pubmed |
pubmed-article:17302588 | pubmed:author | pubmed-author:IsajiShujiS | lld:pubmed |
pubmed-article:17302588 | pubmed:author | pubmed-author:UemotoShinjiS | lld:pubmed |
pubmed-article:17302588 | pubmed:author | pubmed-author:MizunoShugoS | lld:pubmed |
pubmed-article:17302588 | pubmed:author | pubmed-author:UsuiMasanobuM | lld:pubmed |
pubmed-article:17302588 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17302588 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:17302588 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17302588 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17302588 | pubmed:pagination | 24-31 | lld:pubmed |
pubmed-article:17302588 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:meshHeading | pubmed-meshheading:17302588... | lld:pubmed |
pubmed-article:17302588 | pubmed:articleTitle | Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation. | lld:pubmed |
pubmed-article:17302588 | pubmed:affiliation | Department of Hepatobiliary Pancreatic Surgery, Mie University Hospital, Mie, Japan. m-usui@clin.medic.mie-u.ac.jp | lld:pubmed |
pubmed-article:17302588 | pubmed:publicationType | Journal Article | lld:pubmed |